Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy

Int J Cancer. 1993 Nov 11;55(5):748-52. doi: 10.1002/ijc.2910550509.

Abstract

The tissues of 16 patients bearing a T-cell lymphoma of angioimmunoblastic lymphadenopathy type (AILD-TCL) were investigated for the distribution of Epstein-Barr virus (EBV) subtypes 1 and 2. EBV-association had been proven in these cases by polymerase chain reaction (PCR) for EBV-DNA, in situ hybridization (ISH) for EBV-encoded small nuclear RNAs (EBER) and immunohistology for EBV-encoded latent membrane protein (LMP). PCR and EBER-ISH produced mostly identical results, but some cases were positive with only one of the 2 methods employed. LMP was detected in a few large cells of 8/13 cases. Twelve cases were investigated for the distribution of EBV subtypes. One case contained EBV genome of subtype 2, 3 cases contained subtype 1 and 4 cases contained both subtypes. Four cases could not be typed. These findings suggest that in AILD, as in AIDS-associated lymphomas and lymphomas of the lethal midline granuloma type, subtype 2 of EBV may occur, perhaps in relation to an immunodysfunction developing progressively in these patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Viral / analysis
  • Base Sequence
  • DNA, Viral / analysis
  • Herpesvirus 4, Human / classification
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / isolation & purification*
  • Humans
  • Immunoblastic Lymphadenopathy / microbiology*
  • Immunohistochemistry
  • In Situ Hybridization
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • RNA, Small Nuclear / analysis
  • RNA, Viral / analysis
  • Viral Matrix Proteins / analysis

Substances

  • Antigens, Viral
  • DNA, Viral
  • EBV-associated membrane antigen, Epstein-Barr virus
  • RNA, Small Nuclear
  • RNA, Viral
  • Viral Matrix Proteins